Skip to main content

Table 1 Influence of RAMP-O on composite milk SCC

From: Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz. in bovine subclinical mastitis

RAMP-O (mg)

No. of cows

Weeks post treatment

0†

1

2

3

16

6

73.01 ± 10.05

65.79 ± 5.96

63.62 ± 17.94a*

54.65 ± 16.66a**

32

6

72.93 ± 18.42

62.31 ± 19.10

46.54 ± 25.14a

42.34 ± 21.30a*

48

6

71.48 ± 16.07

49.85 ± 23.49

45.01 ± 17.57A**

41.83 ± 14.81A*

Control

6

76.39 ± 14.38

77.20 ± 13.81

85.17 ± 12.15

77.47 ± 14.24

  1. SCC of composite milk in cows before and after subcutaneous injection of RAMP-O in the areas of supramammary lymph node (mean ± S.E. 104 cells/ml)
  2. aP < 0.05, AP < 0.01, compared with the control in the same time
  3. *P < 0.05, **P < 0.01, compared with pretreatment
  4. †Pretreatment